BR9911183A - In-vivo determination of the effects of a pharmaceutical product on blood parameters - Google Patents
In-vivo determination of the effects of a pharmaceutical product on blood parametersInfo
- Publication number
- BR9911183A BR9911183A BR9911183-7A BR9911183A BR9911183A BR 9911183 A BR9911183 A BR 9911183A BR 9911183 A BR9911183 A BR 9911183A BR 9911183 A BR9911183 A BR 9911183A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical product
- living organism
- effects
- blood
- blood parameters
- Prior art date
Links
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
<B>''DETERMINAçãO IN-VIVO DOS EFEITOS DE UM PRODUTO FARMACêUTICO SOBRE OS PARâMETROS SANGUìNEOS''<D> - Métodos para a seleção de um produto farmacêutico a fim de determinar sua eficácia na alteração da viscosidade do sangue de um organismo vivo, compreendendo um instrumento in-vivo dispostos de forma a se acoplar ao sangue que flui dentro do sistema vascular de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre a viscosidade do sangue de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre a deformidade dos eritrócitos no sangue de um organismo vivo; método compreendendo a etapa de introdução de um produto farmacêutico (ou outro composto) no corpo de um organismo vivo e utilização do instrumento in-vivo para determinar o provável efeito do produto farmacêutico introduzido sobre as propriedades tixotrópicas de um organismo vivo.<B> '' IN-LIVE DETERMINATION OF THE EFFECTS OF A PHARMACEUTICAL PRODUCT ON BLOOD PARAMETERS '' <D> - Methods for the selection of a pharmaceutical product in order to determine its effectiveness in altering the blood viscosity of a living organism, comprising an in-vivo instrument arranged to couple with the blood flowing within the vascular system of a living organism; a method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the blood viscosity of a living organism; a method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the deformity of erythrocytes in the blood of a living organism; method comprising the step of introducing a pharmaceutical product (or other compound) into the body of a living organism and using the in-vivo instrument to determine the likely effect of the introduced pharmaceutical product on the thixotropic properties of a living organism.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/013943 WO1999066839A1 (en) | 1997-08-28 | 1999-06-22 | In-vivo determining the effects of a pharmaceutical on blood parameters |
US10323299A | 1999-06-23 | 1999-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9911183A true BR9911183A (en) | 2001-02-13 |
Family
ID=22294085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9911183-7A BR9911183A (en) | 1999-06-22 | 1999-06-22 | In-vivo determination of the effects of a pharmaceutical product on blood parameters |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9911183A (en) |
-
1999
- 1999-06-22 BR BR9911183-7A patent/BR9911183A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20006467L (en) | In-vivo determination of the effects of a pharmaceutical product on blood parameters | |
DK1298436T3 (en) | Process for Identifying Inhibitor Compounds for the Release of Beta-Amyloid Peptide (BAP) | |
WO2003001966A3 (en) | Diagnostic capsule and method of use | |
BR9611047A (en) | Detection process of oxygenase-2 cycle | |
Jamali et al. | Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion | |
BR0210579A (en) | Antibodies, heavy and light chains, pharmaceutical composition and methods of detection of opgl level in biological sample and treatment | |
BR0113663A (en) | Pectin Film Compositions | |
DE69932191D1 (en) | Device for the examination of body fluid | |
CA2421007A1 (en) | Method for detection of htr and htert telomerase-associated rna in plasma or serum | |
FR2801778B1 (en) | CONNECTION ASSEMBLY FOR THE FIELD OF RACHIDIAN OSTEOSYNTHESIS | |
BR9911861A (en) | Farnesyl protein transferase inhibitors with radiosensitizing properties in vivo | |
BR9713921A (en) | Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition | |
BR0309256A (en) | Temperature responsive release systems | |
PT931264E (en) | DIAGNOSTIC METHOD OF ATEROSCLEROSIS | |
PT931265E (en) | DIAGNOSTIC METHOD OF ATEROSCLEROSIS | |
BR9813514A (en) | Agent for the treatment of keratin fibers | |
BR9911183A (en) | In-vivo determination of the effects of a pharmaceutical product on blood parameters | |
BR9810205A (en) | Use of intravenous contrast agents for projection mammography | |
BR0012661A (en) | Treatment Methods and Drug Screening Methods | |
DE60037676D1 (en) | METHOD FOR DIAGNOSIS OF RICKETTSIA PULICIS | |
SE0002287D0 (en) | biotin | |
PT1097140E (en) | IMIDAZOLE DERIVATIVES SUBSTITUTED WITH BIPHENYLSULPHONYL PROCESS FOR THE PREPARATION OF ITS APPLICATION AS A MEDICINE OR DIAGNOSTIC MEDIUM AND A MEDICINAL PRODUCT INCLUDED | |
BR0111726A (en) | Biotin Derivatives | |
BR0213410A (en) | Pharmaceutical uses of bisphosphonates | |
BR0009947A (en) | Antimicrobial conjugate, method of eliminating viable microorganisms, medical device, and method of forming an antimicrobial conjugate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement | ||
B25E | Requested change of name of applicant rejected |
Owner name: VISCO TECHNOLOGIES, INC (US) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME DO TITULAR REQUERIDO ATRAVES DA PETICAO 037183/RJ DE 11/07/2002, POR FALTA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 1773 DE 28/12/2004. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1865 DE 03/10/2006. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: G01N 11/04 (2006.01), G01N 33/15 (2006.0 |